logo_new@0,5x
  • Glycotest
  • About us
    • Management Team
    • Board of Directors
    • Scientific and Medical Advisors
    • Glycotest Investor Presentation
  • Technology
    • Clinical Data
    • Intellectual Property
  • Investors
  • News
  • Contact us
logo_new@0,75x
logo_new@0,5x
  • Glycotest
  • About us
    • Management Team
    • Board of Directors
    • Scientific and Medical Advisors
    • Glycotest Investor Presentation
  • Technology
    • Clinical Data
    • Intellectual Property
  • Investors
  • News
  • Contact us

NetScientific portfolio company, Glycotest Inc., appoints world leading medical advisory board chaired by David Chernoff, M.D.

January 6, 2016
-
News
-
No comments
-
Posted by glycotest
← PREVIOUS POST
Lawrence Cohen, CEO of Glycotest, will be presenting the company at the New York Venture Summit on July 21, 2016.
NEXT POST →
NetScientific appoints diagnostics leader Lawrence Cohen as CEO of Glycotest Inc.

Leave a Comment

Your feedback is valuable for us. Your email will not be published.
Cancel Reply

Please wait...
Submit Comment

Related News

Other posts that you should not miss.

Glycotest is developing a new Test for Detecting Early Stage Liver Cancer with the revolutionary approach of using Glycoproteins as Biomarkers – CEOCFO Magazine

September 3, 2019
-
News

Glycotest19-CEOCFOMagazine-Interview.pdf

Read More →
Posted by Webmaster
1 MIN READ

Glycotest was chosen as one of 50 companies to be in the MedTech Showcase in September 2019

August 22, 2019
-
News

MedTech Innovator Showcase Announcement 6.17.19

Read More →
Posted by Webmaster
1 MIN READ

Case-Control Study of the Glycotest™ HCC Panel vs AFP For the Detection of Early-stage Hepatocellular Carcinoma (NCT03878550)

June 13, 2019
-
News
Read More →
Posted by Webmaster
1 MIN READ

GET IN TOUCH

Meet Us

77 Water Street, Suite 817 New York, NY 10005

Give Us A Call

+1 (646) 722-4339

Send Us A Message

info@glycotest.com

Copyright© All Rights Reserved
Website Designed & Developed by Jason and Company
NetScientific portfolio company, Glycotest Inc., appoints world leading medical advisory board chaired by David Chernoff, M.D. | Glycotest Diagnostics